All data are based on the daily closing price as of January 23, 2025
u

Universal Vision Biotechnology

3218.TWO
6.26 USD
0.09
+1.46%

Overview

Last close
6.26 usd
Market cap
530.76M usd
52 week high
10.65 usd
52 week low
5.85 usd
Target price
6.56 usd

Valuation

P/E
16.129
Forward P/E
N/A
Price/Sales
4.1701
Price/Book Value
5.1271
Enterprise Value
508.56M usd
EV/Revenue
3.9865
EV/EBITDA
8.9374

Key financials

Revenue TTM
127.02M usd
Gross Profit TTM
76.26M usd
EBITDA TTM
50.67M usd
Earnings per Share
0.39 usd
Dividend
N/A usd
Total assets
183.40M usd
Net debt
N/A usd

About

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses for myopia, hyperopia, presbyopia, and astigmatism. Furthermore, it offers eye plastic and micro cosmetic surgery; and aesthetic medicine consulting services, and provides nutritional supplements for eye protection. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan.
  • Symbol
    3218.TWO
  • Exchange
    TWO
  • Isin
    TW0003218004
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
    Ms. Shu-Hsin Lin
  • Headquarter
    Taipei
  • Web site
    https://www.uvb.com.tw/
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top